Kolexia
Borson Chazot Francoise
Médecine générale
Hôpital Louis Pradel
Bron, France
345 Activités
968 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de la thyroïde Carcinomes Tumeurs de l'hypophyse Phéochromocytome Adénomes Nodule thyroïdien Tumeurs neuroendocrines Néoplasie endocrinienne multiple de type 1 Tumeurs du pancréas

Industries

Ipsen
22 collaboration(s)
Dernière en 2023
Eisai
7 collaboration(s)
Dernière en 2022
Lilly
6 collaboration(s)
Dernière en 2023
Merck-Serono
2 collaboration(s)
Dernière en 2022

Dernières activités

An Open-Label Phase 2 Study of Eneboparatide, a Novel PTH Receptor 1 Agonist, in Hypoparathyroidism.
The Journal of clinical endocrinology and metabolism   06 mars 2024
Summary and update on the management of differentiated thyroid cancer in 2023.
Annales d'endocrinologie   03 février 2024
Beyond MEN1, when to think about MEN4? Retrospective study on 5600 patients in the French population & literature review.
The Journal of clinical endocrinology and metabolism   30 janvier 2024
SFE-AFCE-SFMN 2022 consensus on the management of thyroid nodules: Interest and place of thyroid cytology.
Annales de pathologie   12 décembre 2023
Performance of Ffluorocholine PET/CT in MEN1-related primary hyperparathyroidism before initial surgery or for persistent/recurrent disease.
European journal of nuclear medicine and molecular imaging   07 décembre 2023
Factors Associated with Survival in Anaplastic Thyroid Carcinoma: A Multicenter Study from the ENDOCAN-TUTHYREF Network.
Thyroid : official journal of the American Thyroid Association   01 novembre 2023
Thirty Years of Progress Thanks to the Oncogene.
The New England journal of medicine   21 octobre 2023
EXPRESSION OF MENIN IN THE HUMAN THYROID GLAND.
Acta endocrinologica (Bucharest, Romania : 2005)   11 octobre 2023
SAT237 AZP-3601, A Novel PTH 1 Receptor Agonist, Induces Rapid Reduction And Normalization Of Urinary Calcium In Chronic Hypoparathyroid Patients
ENDO 2023 Abstracts Annual Meeting of the Endocrine Society   05 octobre 2023
OR23-04 Treatment Of Chronic Hypoparathyroidism With Eneboparatide (AZP-3601), A Novel PTH 1 Receptor Agonist: Results From A Phase 2 Trial
ENDO 2023 Abstracts Annual Meeting of the Endocrine Society   05 octobre 2023